Athira Pharma (NASDAQ:LONA) CEO Sells 5,156 Shares
Athira Pharma, Inc. (NASDAQ:LONA - Get Free Report) CEO Mark James Litton sold 5,156 shares of the stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price...